Gossamer Bio, Inc. (GOSS)

Gossamer Bio Statistics

Total Valuation

Gossamer Bio has a market cap or net worth of $198.49 million. The enterprise value is $44.89 million.

Market Cap	198.49M
Enterprise Value	44.89M

Important Dates

The next estimated earnings date is Friday, November 15, 2024, before market open.

Earnings Date	Nov 15, 2024
Ex-Dividend Date	n/a

Share Statistics

Gossamer Bio has 226.23 million shares outstanding. The number of shares has increased by 131.91% in one year.

Current Share Class	226.23M
Shares Outstanding	226.23M
Shares Change (YoY)	+131.91%
Shares Change (QoQ)	+5.67%
Owned by Insiders (%)	3.18%
Owned by Institutions (%)	67.12%
Float	187.64M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.02
Forward PS	n/a
PB Ratio	2.46
P/FCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	0.47
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 8.21, with a Debt / Equity ratio of 2.44.

Current Ratio	8.21
Quick Ratio	7.93
Debt / Equity	2.44
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-5.50

Financial Efficiency

Return on equity (ROE) is -863.39% and return on invested capital (ROIC) is -19.87%.

Return on Equity (ROE)	-863.39%
Return on Assets (ROA)	-15.63%
Return on Capital (ROIC)	-19.87%
Revenue Per Employee	$709,941
Profits Per Employee	-$598,904
Employee Count	135
Asset Turnover	0.35
Inventory Turnover	n/a

Taxes

In the past 12 months, Gossamer Bio has paid $4.44 million in taxes.

Income Tax	4.44M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +55.38% in the last 52 weeks. The beta is 1.96, so Gossamer Bio's price volatility has been higher than the market average.

Beta (5Y)	1.96
52-Week Price Change	+55.38%
50-Day Moving Average	0.94
200-Day Moving Average	0.94
Relative Strength Index (RSI)	41.25
Average Volume (20 Days)	675,239

Short Selling Information

The latest short interest is 6.95 million, so 3.07% of the outstanding shares have been sold short.

Short Interest	6.95M
Short Previous Month	7.75M
Short % of Shares Out	3.07%
Short % of Float	3.71%
Short Ratio (days to cover)	7.56

Income Statement

In the last 12 months, Gossamer Bio had revenue of $95.84 million and -$80.85 million in losses. Loss per share was -$0.37.

Revenue	95.84M
Gross Profit	95.84M
Operating Income	-69.42M
Pretax Income	-172.58M
Net Income	-80.85M
EBITDA	-68.23M
EBIT	-69.42M
Loss Per Share	-$0.37

Balance Sheet

The company has $354.49 million in cash and $198.88 million in debt, giving a net cash position of $155.61 million or $0.69 per share.

Cash & Cash Equivalents	354.49M
Total Debt	198.88M
Net Cash	155.61M
Net Cash Per Share	$0.69
Equity (Book Value)	81.53M
Book Value Per Share	0.36
Working Capital	325.72M

Cash Flow

Operating Cash Flow	-3.87M
Capital Expenditures	n/a
Free Cash Flow	-3.87M
FCF Per Share	-$0.02

Margins

Gross margin is 100.00%, with operating and profit margins of -72.43% and -84.36%.

Gross Margin	100.00%
Operating Margin	-72.43%
Pretax Margin	-79.73%
Profit Margin	-84.36%
EBITDA Margin	-71.19%
EBIT Margin	-72.43%
FCF Margin	n/a

Dividends & Yields

Gossamer Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-131.91%
Shareholder Yield	-131.91%
Earnings Yield	-40.32%
FCF Yield	-1.93%

Analyst Forecast

The average price target for Gossamer Bio is $9.20, which is 948.55% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$9.20
Price Target Difference	948.55%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Gossamer Bio has an Altman Z-Score of -3.42 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-3.42
Piotroski F-Score	3